Please ensure Javascript is enabled for purposes of website accessibility

Brainstorm Cell Therapeutics(BCLI)

Nasdaq Capital Market (Nasdaq)

BCLI
Brainstorm Cell Therapeutics Stock Quote
$3.99 -$0.16 -3.9%
Price as of March 2, 2021, 9:00 p.m. EST View Interactive BCLI Charts

Brainstorm Cell Therapeutics Inc.

Interactive Chart


News & Analysis: Brainstorm Cell Therapeutics

All

Market Moves

Key Data Points

Primary metrics and data points about Brainstorm Cell Therapeutics.
Market Cap: $148M
Current Price: $3.99
Day's Range: $3.97 - $4.25
52wk Range: $3.80 - $17.95
Volume: 538,367
Avg Vol 1,227,459

Company Rating

What our community thinks about Brainstorm Cell Therapeutics
CAPS Rating 1 out of 5
 
18 Outperform
14 Underperform
CAPS All Stars
 
4 Outperform
7 Underperform

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company
Powered by Glassdoor

Business Summary

Brainstorm Cell Therapeutics Inc.

Sector: Health Care
Industry: Biotechnology

1325 Avenue of Americas 28th Floor
New York, NY 10019
United States
www.brainstorm-cell.com